|
 
 |
| ERRATUM |
|
| Year : 2022 | Volume
: 13
| Issue : 1 | Page : 83 |
|
Erratum: Effect of selenium on triglyceride and total cholesterol, weight gain, and physical activity on hemodialysis patients: A randomized double-blinded controlled trial
| Date of Web Publication | 26-May-2022 |
Correspondence Address:
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2008-7802.346049
How to cite this article:
. Erratum: Effect of selenium on triglyceride and total cholesterol, weight gain, and physical activity on hemodialysis patients: A randomized double-blinded controlled trial. Int J Prev Med 2022;13:83 |
How to cite this URL:
. Erratum: Effect of selenium on triglyceride and total cholesterol, weight gain, and physical activity on hemodialysis patients: A randomized double-blinded controlled trial. Int J Prev Med [serial online] 2022 [cited 2023 Sep 21];13:83. Available from: https://www.ijpvmjournal.net/text.asp?2022/13/1/83/346049 |
In the article titled “Effect of Selenium on Triglyceride and Total Cholesterol, Weight Gain, and Physical Activity on Hemodialysis Patients: A Randomized Double-Blinded Controlled Trial”, published on allocation ID 63, Issue 1, Volume 13 of International Journal of Preventive Medicine,[1] the affiliation of Abdolamir Atapour, Sahar Vahdat, Mohsen Hosseini, Hamed Mohamadian are written incorrectly as “ Department of Internal Medicine, School of Medicine, Isfahan University of Medical Science, Isfahan, Iran” instead of “ Isfahan Kidney Diseases Research Center, Khorshid medical educational center, Isfahan University of Medical Sciences, Isfahan, Iran”.
| References | |  |
| 1. | Atapour A, Vahdat S, Hosseini M, Mohamadian H. Effect of selenium on triglyceride and total cholesterol, weight gain, and physical activity on hemodialysis patients: A randomized double-blinded controlled trial. Int J Prev Med 2022;13:63.  [Full text] |
|
